Airway management

Preoxygenation strategies for intubation of patients who are critically ill: a systematic review and network meta-analysis of randomised trials

Lancet Respir MedPublished Systematic review and network meta-analysis of randomised trials

Authors' conclusion

Preoxygenation with NIPPV or HFNC rather than facemask oxygen might prevent hypoxaemia during tracheal intubation of adults who are critically ill. Compared with HFNC, NIPPV probably decreases the incidence of hypoxaemia during intubation.

Study context

Population
Critically ill adults (≥18 years) requiring intubation in the ICU or ED
Participants
3,420 adults · 15 studies
Comparison
Non-invasive positive pressure ventilation (NIPPV) vs high-flow nasal cannula (HFNC) vs facemask oxygen for preoxygenation
Outcome
Hypoxaemia during intubation
Methodological detailsfrequentist random-effects network meta-analysis, RoB 2.0, GRADE
  • Frequentist random-effects network meta-analysis
  • RoB 2.0
  • GRADE

Pooled result

As reported in the abstract

Relative risk (95% CI)P value
NIPPV vs HFNCmoderate certainty
0.73(0.55–0.98)
P = 0.032
NIPPV vs Facemask oxygenhigh certainty
0.51(0.39–0.65)
P < 0.0001
HFNC vs Facemask oxygenhigh certainty
0.69(0.54–0.88)
P = 0.0064

Further pooled results

Successful intubation on the first attempt

Not affected by any preoxygenation strategy (all low certainty)

All-cause mortality

No strategy appeared to affect all-cause mortality (very low-to-moderate certainty)

Safety

OutcomeRR (95% CI)P value
Serious adverse eventsNIPPV vs Facemask oxygen · moderate certainty0.30 (0.12–0.77)P = 0.011
Serious adverse eventsNIPPV vs HFNC · low certainty0.32 (0.11–0.91)P = 0.035
Serious adverse eventsHFNC vs Facemask oxygen · low certainty0.95 (0.60–1.51)P = 0.83

Original publication

Preoxygenation strategies for intubation of patients who are critically ill: a systematic review and network meta-analysis of randomised trials. Lancet Respir Med. Published 21 March 2025. doi:10.1016/s2213-2600(25)00029-3

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.